These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 19090486

  • 1. Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
    Yau TO, Chan CF, Gee-San Lam S, Cheung OF, Ching YP, Jin DY, Sham MH, Ng IO.
    J Pathol; 2009 Feb; 217(3):353-61. PubMed ID: 19090486
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG, Wang F, Factor VM, Kaur S, Venkatraman M, Thorgeirsson SS, Arsura M.
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [Abstract] [Full Text] [Related]

  • 3. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
    Horiguchi N, Takayama H, Toyoda M, Otsuka T, Fukusato T, Merlino G, Takagi H, Mori M.
    Oncogene; 2002 Mar 14; 21(12):1791-9. PubMed ID: 11896611
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
    Beraza N, Lüdde T, Assmus U, Roskams T, Vander Borght S, Trautwein C.
    Gastroenterology; 2007 Jun 14; 132(7):2504-17. PubMed ID: 17570222
    [Abstract] [Full Text] [Related]

  • 5. Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma.
    Sivaramakrishnan V, Niranjali Devaraj S.
    Chem Biol Interact; 2009 Aug 14; 180(3):353-9. PubMed ID: 19539802
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
    Wang J, Zhao J, Chu ES, Mok MT, Go MY, Man K, Heuchel R, Lan HY, Chang Z, Sung JJ, Yu J.
    J Pathol; 2013 Aug 14; 230(4):441-52. PubMed ID: 23625826
    [Abstract] [Full Text] [Related]

  • 7. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J, Zhang R, Qiu W, Su Q, Naples M, Adeli K.
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun 14; 296(6):G1287-98. PubMed ID: 19342510
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D3 upregulated protein 1 suppresses TNF-α-induced NF-κB activation in hepatocarcinogenesis.
    Kwon HJ, Won YS, Suh HW, Jeon JH, Shao Y, Yoon SR, Chung JW, Kim TD, Kim HM, Nam KH, Yoon WK, Kim DG, Kim JH, Kim YS, Kim DY, Kim HC, Choi I.
    J Immunol; 2010 Oct 01; 185(7):3980-9. PubMed ID: 20826751
    [Abstract] [Full Text] [Related]

  • 9. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
    Sakamoto K, Maeda S, Hikiba Y, Nakagawa H, Hayakawa Y, Shibata W, Yanai A, Ogura K, Omata M.
    Clin Cancer Res; 2009 Apr 01; 15(7):2248-58. PubMed ID: 19276252
    [Abstract] [Full Text] [Related]

  • 10. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.
    Huang X, Yu C, Jin C, Kobayashi M, Bowles CA, Wang F, McKeehan WL.
    Cancer Res; 2006 Feb 01; 66(3):1481-90. PubMed ID: 16452204
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis.
    Wu W, Yao DF, Qiu LW, Sai WL, Shen JJ, Yu HB, Wu XH, Li YM, Wang YL, Gu WJ.
    Hepatobiliary Pancreat Dis Int; 2009 Oct 01; 8(5):504-9. PubMed ID: 19822494
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
    Glauert HP, Eyigor A, Tharappel JC, Cooper S, Lee EY, Spear BT.
    Toxicol Sci; 2006 Apr 01; 90(2):331-6. PubMed ID: 16434500
    [Abstract] [Full Text] [Related]

  • 13. Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis.
    Ma W, Xia X, Stafford LJ, Yu C, Wang F, LeSage G, Liu M.
    Oncogene; 2006 Jul 13; 25(30):4207-16. PubMed ID: 16501603
    [Abstract] [Full Text] [Related]

  • 14. Mutated IkappaBalpha represses proliferation of immortalized neural progenitor cells and prevents their apoptosis after oxygen-glucose deprivation.
    Zhu C, Liu Z, Gui L, Yao W, Qian W, Zhang C.
    Brain Res; 2008 Dec 09; 1244():24-31. PubMed ID: 18773881
    [Abstract] [Full Text] [Related]

  • 15. Delayed hepatocarcinogenesis through antiangiogenic intervention in the nuclear factor-kappa B activation pathway in rats.
    Dong ZZ, Yao DF, Wu W, Yao M, Yu HB, Shen JJ, Qiu LW, Yao NH, Sai WL, Yang JL.
    Hepatobiliary Pancreat Dis Int; 2010 Apr 09; 9(2):169-74. PubMed ID: 20382589
    [Abstract] [Full Text] [Related]

  • 16. The I{kappa}B kinase {beta}/nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression.
    Hikoso S, Yamaguchi O, Nakano Y, Takeda T, Omiya S, Mizote I, Taneike M, Oka T, Tamai T, Oyabu J, Uno Y, Matsumura Y, Nishida K, Suzuki K, Kogo M, Hori M, Otsu K.
    Circ Res; 2009 Jul 02; 105(1):70-9. PubMed ID: 19478205
    [Abstract] [Full Text] [Related]

  • 17. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.
    Sakurai T, Maeda S, Chang L, Karin M.
    Proc Natl Acad Sci U S A; 2006 Jul 11; 103(28):10544-51. PubMed ID: 16807293
    [Abstract] [Full Text] [Related]

  • 18. Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice.
    Pasparakis M, Luedde T, Schmidt-Supprian M.
    Cell Death Differ; 2006 May 11; 13(5):861-72. PubMed ID: 16470223
    [Abstract] [Full Text] [Related]

  • 19. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models.
    Gerondakis S, Grumont R, Gugasyan R, Wong L, Isomura I, Ho W, Banerjee A.
    Oncogene; 2006 Oct 30; 25(51):6781-99. PubMed ID: 17072328
    [Abstract] [Full Text] [Related]

  • 20. [The effects of p16 and Rb protein expression and NF-kappaB activity on hepatocarcinogenesis].
    Wang ZW, Peng ZH, Tang HM, Qiu GQ, Xing TH, Yang MZ.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 02; 84(3):225-8. PubMed ID: 15059540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.